| Innovative Healing Counseling & Consulting, Llc | |
|
13508 County 1 Cavalier ND 58220-9421 | |
| (701) 520-3655 | |
| (701) 265-4628 |
| Full Name | Innovative Healing Counseling & Consulting, Llc |
|---|---|
| Speciality | Counselor - Professional |
| Location | 13508 County 1, Cavalier, North Dakota |
| Authorized Official Name and Position | Angela Marie Longtin (OWNER/THERAPIST) |
| Authorized Official Contact | 7019220628 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Innovative Healing Counseling & Consulting, Llc 13508 County 1 Cavalier ND 58220-9421 Ph: (701) 520-3655 | Innovative Healing Counseling & Consulting, Llc 13508 County 1 Cavalier ND 58220-9421 Ph: (701) 520-3655 |
| NPI Number | 1649780347 |
|---|---|
| Provider Enumeration Date | 10/07/2017 |
| Last Update Date | 06/20/2018 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649780347 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 469-12-1-01-187 (North Dakota) | Primary |
News Archive
Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).
Results of a long-awaited study of 3,070 American adults at Johns Hopkins and 118 other U.S. medical centers show that treatment with either of the two standard antiviral drug therapies is safe and offers the best way for people infected with hepatitis C to prevent liver scarring, organ failure and death.
Non-steroidal anti-inflammatory drugs (NSAIDs)—including ibuprofen, diclofenac, naproxen and others—are commonly used pain medications that are generally safe but may increase the risk of developing stomach and intestinal ulcers.
Boston Scientific Corporation today announced the completion of its acquisition of Asthmatx, Inc. of Sunnyvale, California. The transaction follows the definitive agreement announced on September 20. Under the terms of the agreement, Boston Scientific purchased all outstanding Asthmatx shares for a total of $193.5 million. Additional payments of up to $250 million are contingent upon achievement of specified revenue-based criteria through 2019. Asthmatx is now an indirect, wholly-owned subsidiary of Boston Scientific.
People who are witnessed by a bed partner to have stopped breathing during sleep may have higher accumulations of an Alzheimer's disease biomarker called tau in an area of the brain that helps with memory, according to a preliminary study released today that will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia, May 4 to 10, 2019.
› Verified 5 days ago